Denali Therapeutics Inc
NASDAQ:DNLI
Denali Therapeutics Inc
NASDAQ:DNLI
Price:
20.77 USD
-2.53%
Market Closed
Updated:
Jun 10, 2024
Denali Therapeutics Inc
Short-Term Investments
|
Denali Therapeutics Inc
Short-Term Investments Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Short-Term Investments Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Short-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Denali Therapeutics Inc
NASDAQ:DNLI
|
Short-Term Investments
$876.3m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Short-Term Investments
$2m
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-64%
|
CAGR 10-Years
-46%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Short-Term Investments
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Short-Term Investments
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Short-Term Investments
$1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
1%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Short-Term Investments
$7.9B
|
CAGR 3-Years
56%
|
CAGR 5-Years
39%
|
CAGR 10-Years
46%
|
See Also
What is Denali Therapeutics Inc's Short-Term Investments?
Short-Term Investments
876.3m
USD
876.3m
USD
Based on the financial report for Mar 31, 2024, Denali Therapeutics Inc's Short-Term Investments amounts to 876.3m USD.
What is Denali Therapeutics Inc's Short-Term Investments growth rate?
Short-Term Investments CAGR 5Y
14%
14%
Over the last year, the Short-Term Investments growth was -28%. The average annual Short-Term Investments growth rates for Denali Therapeutics Inc have been -4% over the past three years , 14% over the past five years .
You don't have any saved screeners yet
